Tailoring lymphadenectomy according to the risk of lymph node metastasis in endometrial cancer

Journal of Obstetrics and Gynaecology Research

Volumn 40, Issue 2, 2014, Pages 317-321

  Todo, Yukiharu ^a   Watari, Hidemichi ^b   Kang, Sokbom ^c   Sakuragi, Noriaki ^b  

^a HOKKAIDO CANCER CENTER   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c National Cancer Center   (South Korea)

Author keywords

Cancer of the endometrium; Gynecologic imaging; Gynecologic oncology; Gynecology

Indexed keywords

CA 125 ANTIGEN;

ARTICLE; CANCER GROWTH; CANCER RISK; CANCER SIZE; CANCER SURGERY; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS LYMPHADENECTOMY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SURGICAL RISK; THERAPY EFFECT; ENDOMETRIAL NEOPLASMS; PATHOLOGY; PATIENT SELECTION;

ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT;

EID: 84898011767     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/jog.12309     Document Type: Article

References (20)

1. King SB 3rd, Lembo NJ, Weintraub WS et al. A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST). N Engl J Med 1994; 331: 1044-1050.
2. King SB 3rd, Barnhart HX, Kosinski AS et al. Angioplasty or surgery for multivessel coronary artery disease: Comparison of eligible registry and randomized patients in the EAST trial and influence of treatment selection on outcomes. Emory Angioplasty versus Surgery Trial Investigators. Am J Cardiol 1997; 79: 1453-1459.
3. ASTEC study group. Efficacy of systematic pelvic lymphad-enectomy in endometrial cancer (MRC ASTEC trial): A randomized study. Lancet 2009; 373: 125-136.
4. Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N. Survival Effect of Para-aortic Lymphadenectomy in Endometrial Cancer (SEPAL Study): A retrospective cohort analysis. Lancet 2010; 375: 1165-1172.
5. Mariani A, Webb MJ, Galli L, Podratz KC. Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer. Gynecol Oncol 2000; 76: 348-356.
6. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med 2000; 342: 1878-1886.
7. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000; 342: 1887-1892.
8. McKee M, Britton A, Black N, McPherson K, Sanderson C, Bain C. Methods in health services research. Interpreting the evidence: Choosing between randomized and non-randomised studies. BMJ 1999; 319: 312-315.
9. Ballester M, Dubernard G, Lecuru F et al. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: A prospective multicenter study (SENTI-ENDO). Lancet Oncol 2011; 12: 469-476.
10. Barlin JN, Khoury-Collado F, Kim CH et al. The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: Beyond removal of blue nodes. Gynecol Oncol 2012; 125: 25-30.
11. Kim CH, Soslow RA, Park KJ et al. Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging. Int J Gynecol Cancer 2013; 23: 964-970.
12. Abu-Rustum NR, Barakat RR. Observations on the role of circumflex iliac node resection and the etiology of lower extremity lymphedema following pelvic lymphadenec-tomy for gynecologic malignancy. Gynecol Oncol 2007; 106: 4-5.
13. Todo Y, Yamamoto R, Minobe S et al. Risk factors for postoperative lower-extremity lymphedema in endometrial cancer survivors who had treatment including lymphadenectomy. Gynecol Oncol 2010; 119: 60-64.
14. Hareyama H, Ito K, Hada K et al. Reduction/prevention of lower extremity lymphedema after pelvic and para-aortic lymphadenectomy for patients with gynecologic malignacies. Ann Surg Oncol 2012; 19: 268-273.
15. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 1987; 60: 2035-2041.
16. Mariani A, Webb MJ, Keeney GL, Hoddock MG, Calori G, Podratz KC. Low-risk corpus cancer: Is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol 2000; 182: 1506-1519.
17. Milam MR, Java J, Walker JL, Metzinger DS, Parker LP, Coleman RL. Nodal metastasis risk in endometrioid endome-trial cancer. Obstet Gynecol 2012; 119: 286-292.
18. Todo Y, Okamoto K, Hayashi M et al. A validation study of a scoring system to estimate the risk of lymph node metastasis for patients with endometrial carcinoma for tailoring the indication of lymphadenectomy. Gynecol Oncol 2007; 104: 623-628.
19. Kang S, Kang WD, Chung HH et al. Preoperative identification of a low-risk group for lymph node metastasis in endo-metrial cancer: A Korean gynecologic oncology group study. J Clin Oncol 2012; 30: 1329-1334.
20. Hricak H, Rubinstein LV, Gherman GM, Karstaedt N. MR imaging evaluation of endometrial carcinoma: Results of an NCI cooperative study. Radiology 1991; 179: 829-832.